Key earnings releases. Moderna, Siemens, Square, Zoetis, Deutsche Post, Merck KGaA, Adidas, Nintendo, Glencore, Bayer, Crédit Agricole, KBC, Swisscom , Zalando...
- Valneva obtains positive results for the pivotal phase III study with its single injection chikungunya vaccine candidate.
- Adidas: the group has raised its sales and profitability outlook for the year as a whole, despite a downturn in China, where Western brands faced a call for a boycott of their products at the end of March.
- Atlantia: the Italian dealer returned to profit in the first half.
- Bayer: 2021 guidance raised despite weak Q2 results.
- Booking: the stock gained 3% after the close of Wall Street, after the publication of strong quarterly results.
- Deutsche Lufthansa: the company reports slightly lower than expected losses and its first positive cash flow since the crisis.
- Evonik: 2021 guidance raised.
- MetLife: Q2 results beat expectations, allowing the stock to rise by 1.6% after the session.
- Siemens: 2021 growth targets raised slightly.
- Uber: the stock loses more than 4% after the release of mixed quarterly results.
- WPP: 2021 targets raised.
- Zurich Insurance takes over Deutsche Bank 's financial advisor network in Italy.
- Rolls-Royce enters into exclusive discussions with Bain Capital on the sale of ITP Aero for a valuation that could reach $1.9bn, according to the latest rumors.
- Bayer is buying Vividion Therapeutics for $2 billion.
- Robinhood shares soared 50% yesterday.
- General Motors lost 8% after disappointing results.
- Novavax soars 21% after receiving an EU order for its Covid vaccine.
- Temenos wins a contract with Australian bank Alex.
- Weber's IPO price is lower than expected.